CIPDAPLA 5

Description

CIPDAPLA 5 Tablet contains Dapagliflozin Propanediol Monohydrate 5mg per tablet and is a prescription medicine primarily used for the management of Type 2 Diabetes Mellitus.

Mechanism of Action

Dapagliflozin is a sodium-glucose co-transporter 2 (SGLT2) inhibitor. It acts by blocking the SGLT2 protein in the kidneys, thereby preventing the reabsorption of glucose from the urine back into the bloodstream. This results in the excretion of excess glucose through urine, lowering blood sugar levels independently of insulin action.

Indications

• Type 2 Diabetes Mellitus: Can be used alone or with other antidiabetic medicines such as metformin, sulfonylureas, or insulin.

• Cardiovascular Benefits: Helps reduce the risk of hospitalization due to heart failure and other heart-related complications in diabetic patients with established cardiovascular disease or multiple risk factors.

Benefits

• Reduces fasting and post-meal (postprandial) blood glucose levels.

• May assist in lowering blood pressure and body weight.

• Reduces risk of long-term complications of diabetes including kidney damage, blindness, nerve damage, stroke, and heart attack.

• Can reduce risk of heart-related events in high-risk patients.

Dosage & Administration

• Typical dose: 5mg once daily.

• Take at the same time each day.

• Can be taken with or without food; swallow whole, do not chew or break.

• Dosage may be modified by your doctor based on your medical condition and response.

Common Side Effects

• Genital fungal infection

• Urinary tract infection (UTI)

• Increased urination/polyuria

• Nausea, vomiting

• Dehydration (from excess fluid loss)

• Nasopharyngitis (inflammation of the throat and nasal passages)
  Most side effects resolve as your body adapts, but notify your doctor if they persist.

Important Safety Information

• May be unsafe in patients with moderate to severe kidney disease, or on dialysis; dose adjustment or avoidance may be necessary.

• Monitor for symptoms of low blood sugar especially if used with other antidiabetics, or if a meal is missed.

• Maintain good hygiene to help prevent genital and urinary tract infections.

• Drink plenty of fluids to prevent dehydration—especially important in the elderly.

• Consult your doctor before use if pregnant or breastfeeding.

Laboratory Monitoring

• Regularly check fasting and postprandial blood sugar.

• Monitor kidney function during treatment.

• Routine HbA1c testing to assess long-term control.

Note: CIPDAPLA 5 Tablet is part of a diabetes management program that should include diet, exercise, and regular monitoring. Use only as prescribed by your physician.